Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 14, 2024
[ Wed, Aug 14th 2024
] - WOPRAI
[ Wed, Aug 14th 2024
] - WOPRAI
[ Wed, Aug 14th 2024
] - WOPRAI
[ Wed, Aug 14th 2024
] - WOPRAI
[ Wed, Aug 14th 2024
] - WOPRAI
[ Wed, Aug 14th 2024
] - WOPRAI
[ Wed, Aug 14th 2024
] - WOPRAI
[ Wed, Aug 14th 2024
] - WOPRAI
[ Wed, Aug 14th 2024
] - WOPRAI
Tue, August 13, 2024
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
[ Tue, Aug 13th 2024
] - WOPRAI
Jason Kolbert Initiated (ANVS) at Strong Buy and Held Target at $21 on, Aug 13th, 2024
Jason Kolbert of EF Hutton, Initiated "Annovis Bio, Inc." (ANVS) at Strong Buy and Held Target at $21 on, Aug 13th, 2024.
Jason has made no other calls on ANVS in the last 4 months.
There are 3 other peers that have a rating on ANVS. Out of the 3 peers that are also analyzing ANVS, 0 agree with Jason's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jason
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Wednesday, July 17th, 2024
- Elemer Piros of "Rodman & Renshaw" Reiterated at Strong Buy and Held Target at $67 on, Tuesday, July 2nd, 2024
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $26 on, Tuesday, April 30th, 2024
